menu ☰
menu ˟

Public Health Well

Hundreds of clinics in US offering stem cell therapies without FDA approval

Ajay E. Kuriyan VANCOUVER, British Columbia — A cross-sectional, clinical study of stem cell therapy clinics found 40 companies with 76 clinics across the United States offering patients non-FDA approved “cell therapy” for ocular conditions, according to a ...

Baseline ocular characteristics improve patient selection for ocriplasmin treatment

David S. Boyer VANCOUVER, British Columbia — Specific baseline ocular characteristics can help to identify patients with vitreomacular adhesion resolution who can benefit from ocriplasmin treatment, according to a speaker here. This sub-analysis of the pha ...

VIDEO: Allergan shares abicipar topline results

VANCOUVER, British Columbia — At OIS Retina here, C. David Nicholson, PhD, executive vice president and head of research and development at Allergan, discusses the topline results of two phase 3 studies of abicipar for the treatment of patients with wet-AM ...

Pacing lead receives expanded labeling from FDA

Medtronic announced that a cardiac pacing lead has received labeling expansion from the FDA for patients who require His-bundle pacing. The pacing lead (SelectSecure MRI SureScan Model 2820, Medtronic) is the only approved device on the market for His-bund ...

Opioids: Why 'dangerous' drugs are still being used to treat pain

Despite links to UK hospital deaths and a US addiction crisis, opioids remain the painkiller of choice. ...

VIDEO: FFB showcases progress in treating inherited retinal diseases

VANCOUVER, British Colombia At OIS Retina here, Jason Menzo, COO of the Foundation Fighting Blindness, discusses the foundation’s symposium on the progress being made by companies in treating inherited retinal diseases. ...

Enhanced immigration enforcement in US could worsen HIV epidemic

Since the 2016 United States elections, immigrants from Latin America with HIV have become more anxious about the possibility of being deported to their home countries and losing access to medical care, according to a recent Viewpoint published in The Lanc ...

AACR presents grant for transformative cancer research

The American Association for Cancer Research named Birgit Knoechel, MD, PhD, as the inaugural recipient of the AACR-The Mark Foundation NextGen Grant for Transformative Cancer Research. The grant program, AACR’s flagship funding initiative, is designed to ...

DePuy Synthes launches new suture for rotator cuff surgery

DePuy Synthes, a franchise of Johnson & Johnson Medical Devices Companies, recently announced the limited launch of the Dynacord suture. The Dynacord suture is designed to repair soft tissues, such as the rotator cuff in the shoulder, and to prevent lo ...

Wearable patch measures cortisol in sweat

Researchers from Stanford University have designed a wearable device that measures how much cortisol a person is producing through sweat, according to a press release from the university. “Our aim was to develop a device that can give us more information a ...

4 recent device updates in cardiac, vascular intervention

Cardiology Today’s Intervention has compiled a list of four recent updates relevant to devices for cardiac and vascular intervention. FDA approves next-generation device for transcatheter mitral valve repair Abbott announced that the FDA has approved a nex ...

Ambitious targets set for social housing

The Department of Public Expenditure and Reform has recommended that people on social housing schemes supporting private rental accommodation should be asked to pay a progressively larger share of the rent as their household income increases. ...

Brexit: White Paper, Westminster chaos and few choices

On Friday 6 July Theresa May delivered the Chequers statement on the future relationship between the EU and UK.  Over the next ten days, despite the resignations of David Davis and Boris Johnson, the ice entombing the Brexit negotiations imperceptibly crac ...

Admit it, older people – you are addicted to your phones, too | Sophia Ankel

Over-reliance on mobiles isn’t just the scourge of the young, and it has a damaging effect on families ...

Transepithelial PRK effectively corrects myopic astigmatism

Patients with low to moderate myopic astigmatism who underwent transepithelial PRK experienced safe, predictable outcomes, according to a study. The retrospective study included 47 eyes of 36 patients with low to moderate myopic astigmatism who underwent t ...

Global coverage of HBV treatment remains low despite declining costs

The international market price of generic tenofovir, prequalified by WHO for hepatitis B virus infection, declined more than 85% from 2004 to 2016, according to recent MMWR data. Still, only one in six patients diagnosed with HBV infection worldwide receiv ...

Nutrition bar improves lung function in overweight, obese teens with asthma

Joyce McCann Ashutosh Lal Teens with overweight or obesity and uncontrolled asthma who consumed two nutritional supplement bars daily and attended nutrition and exercise classes experienced improved lung function and a better quality of life without losing ...

Trial to assess feasibility, safety of CAR T-cell therapy for relapsed pediatric central nervous system tumors

Nicholas A. Vitanza A clinical trial is underway to examine the role of chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory HER-2-positive central nervous system tumors. “[Although] survival rates have improve ...

Traveller families living in 'cold, damp conditions'

Traveller families across 18 sites in Galway are living in overcrowded, cold and damp conditions, according to a report which surveyed the living conditions of Travellers across Ireland. ...

FDA approves Nivestym, biosimilar to Neupogen, for treatment of neutropenia

The FDA approved the biosimilar filgrastim-aafi, designed to promote white blood cell recovery among individuals who have undergone treatments that can trigger neutropenia. Filgrastim-aafi (Nivestym, Pfizer) is the second approved biosimilar to filgrastim ...